Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Amy Goodrich"'
Autor:
Edina Komlodi-Pasztor, Marta Escarra-Senmarti, Danielle A. Bazer, Aastha Bhatnagar, Carlos A. Perez Heydrich, Marcus Messmer, Richard F. Ambinder, Douglas E. Gladstone, Laura Clayton, Amy Goodrich, Laura Schoch, Nina Wagner-Johnston, Christopher J. VandenBussche, Peng Huang, Matthias Holdhoff, Maximillian Rosario
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The monoclonal antibody rituximab improves clinical outcome in the treatment of CD20-positive lymphomatous neoplasms, and it is an established drug for treatment of these cancers. Successful mRNA COVID-19 (SARS-CoV-2) vaccination is extremely importa
Externí odkaz:
https://doaj.org/article/231eb2a41b7d476ea9cd7853570c0c4f
Autor:
Lekha Racharla, Benjamin Borokhovsky, Naveed Rahman, Akhil Kher, Amy Goodrich-Harris, Apurva Vijay Vyas
Publikováno v:
Journal of the American College of Cardiology. 81:3809
Autor:
Mazyar Shadman, Amy Goodrich
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Mazyar Shadman, MD, MPH, and Amy Goodrich, CRNP, reviewed data regarding the mechanistic activity, efficacy, and safety of approved and emerging therapeutic options for chronic lymphocytic leukemia (CLL) and strategies for managing adverse events ass
Autor:
Amy Goodrich
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Tumor lysis syndrome (TLS) and neutropenia are significant toxicities in the treatment of chronic lymphocytic leukemia (CLL). Both TLS and neutropenia can lead to potentially life-threatening complications for patients with chronic lymphocytic leukem
Autor:
Lekha Racharla, Zeel J. Patel, Akhil Kher, Amogh M. Joshi, Amy Goodrich-Harris, Theresa Maitz
Publikováno v:
Journal of the American College of Cardiology. 79:2617
Publikováno v:
Journal of the American College of Cardiology. 79:2934
Publikováno v:
Clinical Journal of Oncology Nursing. 21:2-12
Background Multiple treatment options, combined with disease heterogeneity, have created nursing challenges in the management of adverse events (AEs) during antilymphoma therapy. Testing has revealed that less than half of participating nurses correc
Publikováno v:
Advances in Pulmonary Hypertension. 19:35-36
Publikováno v:
Journal of the American College of Cardiology. 75:2909
Eosinophilic myocarditis (EM) was first described in 1936 and is an uncommon etiology of heart failure. Our understanding of its pathophysiology has improved significantly since then, though treatment still poses a significant challenge. A potential
Publikováno v:
Journal of the American College of Cardiology. 75:3169